abstracts

0

Page précédente

Abstracts Strasbourg 2004

Type présentation Jour(s) N° Session Auteurs Titre Adresses
Poster 26-28   22  P070 M Canal-Rafffin (1); K Titier (1); E Déridet (1); B Martinez (1); A Abouelfath (1); S Gromb (1); M Molimard (1); N Moore (1); Myocardium distribution of Sertindole and its metabolite Dehydrosertindole in the guinea-pig 
Abstract complet
(1) EA-3676, IFR 99, Université Victor Segalen, Bordeaux;
Poster 26-28   22  P071 A Pathak (1); B Bourdet (2); JL Montastruc (1); J Amar (2); JM Senard (1); Should nocturnal systolic blood pressure be treated in patients with dysautonomia-related orthostatic hypotension? Insight from a prospective survival study 
Abstract complet
(1) Service de Pharmacologie Clinique, Faculté de médecine, Toulouse; (2) Service d’HTA, CHU de Toulouse, Toulouse;
Poster 26-28   22  P072 F Jaffre (1); JM Launay (1); C Nebigil (2); L Monassier (3); L Maroteaux (2); Blockade of the serotonin 5-HT2B receptor prevents ß-adrenergic or AngII stimulation-induced cardiac hypertrophy via inhibition of cytokines release 
Abstract complet
(1) Service Biochimie, Hôpital Lariboisière, Paris; (2) CNRS/INSERM, IGBMC, Illkirch; (3) LNPCV INSERM E0333, Faculté de Médecine, Strasbourg;
Poster 26-28   22  P073 A Pathak (1); M Galinier (2); J Fourcade (2); JL Montastruc (1); JM Senard (1); Ventricular Repolarisation Dynamicity as a new discriminant marker to identify obese patients at risk of drug-induced Torsade de pointes 
Abstract complet
(1) INSERM U 586, Service de Pharmacologie Clinique / Faculté de Méd, Toulouse; (2) Service de Cardiologie, CHU de Toulouse, Toulouse;
Poster 26-28   22  P074 P Tsibiribi (1); M Belkhiria (1); C Bui-Xuan (1); H Malonne (2); B Bui-Xuan (1); C Lombard-Bohas (3); A Tabib (4); J Descotes (5); Q Timour (1); Mechanism of 5-fluouracil cardiotoxicity: Spasm, apoptosis or necrosis? 
Abstract complet
(1) Department of Medical Pharmacology, Université Claude Bernard, Lyon; (2) Department of Physiology and Pharmacology, Université Libre de Bruxelles, Bruxelles, Belgique; (3) Medical Oncology Unit, H. E. Herriot, Hospices Civils de Lyon, Lyon; (4) Department of Pathology, Hôpital L. Pradel, Bron; (5) Poison & Pharmacovigilance Center, Hospices Civils de Lyon, Lyon;
Poster 26-28   22  P075 F Goirand (1); E Samain (2); D Christophe (3); A Lombet (3); JF Renaud (3); Influence of etomidate and sevoflurane on the angiotensinII- induced aorta vasoconstriction of WKY rats: role of intracellular calcium mobilization 
Abstract complet
(1) UMR 1154, Faculté de Pharmacie, Châtenay-Malabry; (2) Service d’Anesthesie Réanimation, CHU de Besançon, Besançon; (3) UMR 8078, Centre Chirurgical Marie Lannelongue, Le Plessis Robinson;
Poster 26-28   22  P076 B Aleil (1); C Ravanat (1); JP Cazenave (1); A Heitz (2); C Gachet (1); Flow cytometric assessment of VASP phosphorylation: an index of the efficacy of clopidogrel in patients with atherothrombotic diseases 
Abstract complet
(1) INSERM U311, EFS-Alsace, Strasbourg; (2) Service de Cardiologie, Clinique de l’Orangerie, Strasbourg;
Poster 26-28   22  P077 K Titier (1); M Canal (1); A Abdelilah (1); S Gromb (2); M Molimard (1); N Moore (1); Determination of myocardium binding of a series of antipsychotic drugs: comparison with their ability to induce arrhythmia and sudden death in clinical practice 
Abstract complet
(1) Laboratoire de Pharmacologie Clinique et Toxicologie, Hopital Pellegrin-Université Bordeaux 2, Bordeaux; (2) Service de Médecine Légale, Hopital Pellegrin-Université Bordeaux 2, Bordeaux;
Poster 26-28   22  P078 JL Cracowski (1); S Girolet (2); B Imbert (2); C Seinturier (2); F Stanke-Labesque (1); J Bessard (1); A Boignard (3); G Bessard (1); P Carpentier (2); Effect of vitamin E in systemic sclerosis: a double blind, randomized, controlled clinical trial of efficacy based on urinary isoprostane measurement 
Abstract complet
(1) Laboratoire de Pharmacologie HP2, Faculté de Médecine, Grenoble; (2) Département Pluri-disciplinaire de Médecine, CHU de Grenoble, Grenoble; (3) Centre d’Investigation Clinique, CHU de Grenoble, Grenoble;
Poster 26-28   22  P079 K Lacut (1); E Oger (1); JH Abalain (2); MP Moineau (3); D Mottier (1); Effect of oral and transdermal 17 beta-estradiol combined with progesterone on homocysteine metabolism in postmenopausal women: a randomised placebo-controlled trial 
Abstract complet
(1) Département de Médecine Interne et Pneumologie, CHU, Brest; (2) Laboratoire de Biochimie et Biologie Moléculaire, CHU, Brest; (3) Laboratoire de Biophysique, CHU, Brest;
Poster 26-28   22  P080 H Millart (1); Concentration-dependent aminooxyacetic acid (AOAA) effects on cardiac efficiency of isolated electrically-paced perfused rat heart 
Abstract complet
(1) Laboratoire de Pharmacologie Médicale, Faculté de Médecine, Reims;
Poster 26-28   22  P081 K Mobacher (1); P Diemunsch (2); S Doutreleau (1); R Lupescu (2); A Schaefer (1); P Plobner (2); B Mettauer (1); F Piquard (1); B Geny (1); Inhaled nitric oxide improves hemodynamic changes following acute CO2 plus 10% N20 pulmonary embolism 
Abstract complet
(1) EA 3072, Faculté de Médecine, Strasbourg; (2) Service d’Anesthésiologie, Hôpitaux Universitaires de Strasbourg, Strasbourg;
Poster 26-28   22  P082 A Pathak (1); JM Senard (1); JL Montastruc (1); P Maury (2); Resumption of atrio-ventricular conduction by levosimendan after radiofrequency ablation of the AV node: a new medical treatment for conduction abnormalities? 
Abstract complet
(1) Service de Pharmacologie Clinique, Faculté de médecine, Toulouse; (2) Service de Cardiologie, Faculté de Médecine, Toulouse;

Page précédente